Source:http://linkedlifedata.com/resource/pubmed/id/10477677
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
1999-9-29
|
pubmed:abstractText |
Cytogenetic abnormalities of chromosome arm 9p occur frequently in children with acute lymphoblastic leukemia (ALL). We analyzed 201 such cases (11%) in 1,839 children with newly diagnosed ALL treated between 1989 and 1995 on risk-adjusted protocols of the Children's Cancer Group (CCG). The majority of patients (131; 65%) with a 9p abnormality were classified as higher risk. Nearly all patients had complex karyotypes; most cases had deletions of 9p, add/der(9p), a dicentric involving chromosome arm 9p, and/or balanced translocations and inversions involving 9p. Event-free survival (EFS) estimates at 6 years for patients with and without a 9p aberration were 61% (standard deviation [SD] = 5%) and 76% (SD = 2%; P <.0001). In addition, patients with a 9p abnormality had an increased cumulative incidence of both marrow (P =.04) and central nervous system (P =.0001) relapses. Overall survival also was significantly worse for patients with an abnormal 9p (P <.0001). These effects were most pronounced in standard-risk patients (age 1 to 9 years with white blood cell count <50,000/microL): 6-year EFS of 61% (SD = 9%) versus 80% (SD = 2%; P <.0001). Also, a 9p aberration was an adverse risk factor for B-lineage, but not T-lineage patients. The effect of 9p status on EFS was attenuated, but maintained in a multivariate analysis of EFS after adjustment for Philadelphia chromosome status, age, white blood cell (WBC) count, sex, race, and ploidy group (P =.01). Thus, abnormalities of chromosome arm 9p identify a subgroup of standard-risk patients with increased risk of treatment failure.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0006-4971
|
pubmed:author |
pubmed-author:ArthurD CDC,
pubmed-author:BostromB CBC,
pubmed-author:GaynonP SPS,
pubmed-author:HeeremaN ANA,
pubmed-author:HutchinsonRR,
pubmed-author:LangeB JBJ,
pubmed-author:Liu-MaresWW,
pubmed-author:NachmanJ BJB,
pubmed-author:SatherH NHN,
pubmed-author:SenselM GMG,
pubmed-author:SteinherzP GPG,
pubmed-author:UckunF MFM
|
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
94
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1537-44
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:10477677-Child,
pubmed-meshheading:10477677-Child, Preschool,
pubmed-meshheading:10477677-Chromosome Aberrations,
pubmed-meshheading:10477677-Chromosomes, Human, Pair 9,
pubmed-meshheading:10477677-Female,
pubmed-meshheading:10477677-Humans,
pubmed-meshheading:10477677-Infant,
pubmed-meshheading:10477677-Male,
pubmed-meshheading:10477677-Multivariate Analysis,
pubmed-meshheading:10477677-Precursor Cell Lymphoblastic Leukemia-Lymphoma,
pubmed-meshheading:10477677-Risk Factors
|
pubmed:year |
1999
|
pubmed:articleTitle |
Association of chromosome arm 9p abnormalities with adverse risk in childhood acute lymphoblastic leukemia: A report from the Children's Cancer Group.
|
pubmed:affiliation |
Department of Genetics, Hughes Institute, St Paul, MN, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.
|